SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Annual Wellness Visit, Subsequent — Johnny Cash — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJohnny Cash
Date of birth1932-02-26
IdentifiersMRN HR-ML004-SYN-TD; SSN (made up) 000-04-8125
Document date2003-04-24
AuthorGideon Hale, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Cash is a 71-year-old man with type 2 diabetes complicated by autonomic and peripheral neuropathy, neurogenic orthostatic hypotension, and severe primary open-angle glaucoma, who returns for his subsequent annual wellness visit four weeks after his endocrinology consultation. Sitagliptin and low-dose midodrine were started then. He completed the health risk assessment before the visit, with a family member reading the questions aloud because of his low vision. He stands up in stages, sleeps with the head of the bed raised, and wears waist-high compression; the lightheadedness on standing is less frequent, and he has had no falls since the consultation. His home glucose readings show no values below 70 mg/dL. He uses both eye drops as prescribed and has added no over-the-counter medicines. He is recording at home and writing most days. [S]

ElementDetail
VisitSubsequent annual wellness visit
ContextHealth risk assessment completed before the visit with a family member reading the questions
Safety eventsNo falls since the endocrinology consultation; no emergency visits or hospital stays since his first visit
MedicinesAdherent; pill organizer filled by a family member; both eye drops in use; no new over-the-counter medicines
Active conditionsType 2 diabetes with autonomic and peripheral neuropathy, orthostatic hypotension, glaucoma, mild diabetic retinopathy, and hyperlipidemia
Functional statusIndependent in basic activities of daily living; walks with a cane; does not drive

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthFair, and better since standing up has become easier
PsychosocialA family member helps at home and comes to visits; active church community; writing and recording at home give purpose; no loneliness reported
BehavioralNo tobacco use; no alcohol; walks short distances with a cane; follows a carbohydrate-consistent diet; sleeps about seven hours
Activities of daily livingIndependent in bathing, dressing, eating, toileting, and transfers
Instrumental activities of daily livingManages his own money and telephone; a family member fills his pill organizer and drives him
Home safetySmoke detectors working; dim hallway and stair lighting; handrail on one side of the stairs only
FallsTwo falls in the six months before his first visit, none since the consultation; afraid of falling again
Hearing and visionNo hearing concern; tunnel vision and difficulty in dim light from glaucoma; dilated eye examination two months ago
BladderNo urgency, incontinence, or difficulty emptying
MemoryNo concerns from him or his family

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight down about 1 kg since the consultation with diet; no fever or appetite change
EyesPositiveLong-standing tunnel vision and poor vision in dim light; no eye pain, redness, or stinging from the drops
Ears, nose, mouth, and throatNegativeNo hearing change or mouth sores
CardiovascularPositiveLightheaded on standing quickly, less often than before; no fainting, chest pain, palpitations, or ankle swelling
RespiratoryNegativeNo cough, sputum, or breathlessness
GastrointestinalNegativeNo nausea, diarrhea, or constipation on metformin
GenitourinaryNegativeNo urinary urgency, incontinence, or retention
MusculoskeletalPositiveLeg weakness; walks with a cane; no falls since the consultation
IntegumentaryNegativeNo foot sores, blisters, or color change on daily foot checks
NeurologicalPositiveNumbness of both feet to the ankles, unchanged; no new weakness or headache
PsychiatricNegativeMood good; sleeps well; PHQ-2 score 0
EndocrineNegativeNo shakiness, sweating, or confusion suggesting low glucose; no excess thirst or urination
HematologicNegativeNo easy bruising or bleeding

13 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 500 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with mealsOral route2001-05-06 to 2003-02-27completedS
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with mealsOral route2003-02-27activeS
Sitagliptin 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2003-03-27activeS
Atorvastatin 40 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2003-02-27activeS
Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtimeOne drop in each eye at bedtimeOphthalmic route2000-09-11activeS
Dorzolamide 2% ophthalmic solution, one drop in each eye twice dailyOne drop in each eye twice dailyOphthalmic route2003-02-27activeS
Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PMOne tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bedOral route2003-03-27 to 2003-05-29completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2003-04-24Body height188cmS
2003-04-24Body weight94.2kgS
2003-04-24Body mass index (BMI) [Ratio]26.7kg/m2S
2003-04-24Systolic blood pressure138mm[Hg]S
2003-04-24Diastolic blood pressure76mm[Hg]S
2003-04-24Heart rate75/minS
2003-04-24Respiratory rate16/minS
2003-04-24Body temperature36.6CelS
2003-04-24Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2003-04-24Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2003-04-24Total score [AUDIT-C]0{score}S

Physical Exam

Vital signs recorded on 2003-04-24; see the Vital Signs section. [S]

SystemFinding
ConstitutionalAlert, wry, and well-appearing; weight 94.2 kg, down from 95.0 kg at the consultation
EyesConjunctivae quiet; pupils equal; constricted fields to confrontation in both eyes
Ears, nose, and throatCanals clear; oral mucosa moist
NeckNo thyroid enlargement or nodes; no carotid bruits
CardiovascularRegular rhythm; no murmur; blood pressure 138/76 mmHg seated and 116/70 mmHg after three minutes standing, heart rate 75 to 78, with mild lightheadedness; no edema
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; no masses or aortic bruit
FeetSkin intact with no ulcers or calluses; 10-g monofilament and vibration sensation reduced to the ankles in both feet; dorsalis pedis and posterior tibial pulses present; well-fitting protective shoes
MusculoskeletalTimed Up and Go 14 seconds with a cane; needs his arms to rise from a chair
NeurologicalOriented; conversation, recall, and reasoning normal by direct observation; reduced ankle reflexes
PsychiatricEuthymic and engaged; judgment and insight intact
SkinNo suspicious lesions on the exposed skin

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intakeactiveconfirmed E11.43S — Synthetic modern diagnosis linked to the publicly reported diabetes and autonomic neuropathy.
Neurogenic orthostatic hypotension from diabetic autonomic neuropathyactiveconfirmed I95.1S — Synthetic finding; explains the autonomic symptoms once labeled Shy-Drager syndrome.
Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feetactiveconfirmed E11.42S — Synthetic finding linked to his description of numb lower extremities.
Primary open-angle glaucoma, both eyes, severe stageactiveconfirmed H40.1133S — Synthetic modern diagnosis; the type and stage are not documented historically.
Mild nonproliferative diabetic retinopathy without macular edema, both eyesactiveconfirmed E11.3293S — Synthetic finding from the dilated eye examination.
Hyperlipidemiaactiveconfirmed E78.5S — Synthetic finding from the baseline LDL cholesterol.
History of recurrent pneumoniaactiveconfirmed Z87.01S — Synthetic modern coding of the documented recurrent pneumonia; supports pneumococcal vaccination.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccineUp to dateHigh-dose vaccine given last season; next dose due when the next season's vaccine is available
COVID-19 vaccineDueRecommended at his age and with diabetes; he will get it at his pharmacy
Pneumococcal vaccineUp to datePCV20 given at the first visit two months ago; no further doses needed
Recombinant zoster vaccineDueDose 1 planned for the three-month review, dose 2 two to six months later
RSV vaccineDueRecommended at 60 to 74 with diabetes and its complications; single dose before the respiratory season
Tetanus boosterDueNo booster on record; he will check his pharmacy records
Diabetic eye examinationUp to dateDilated examination two months ago with the eye clinic, which follows his glaucoma and mild retinopathy; repeat yearly
Diabetic foot examinationCompleted todayNo ulcer; loss of protective sensation known; examined at every visit
Kidney screeningUp to dateUrine albumin-creatinine ratio and eGFR normal at the first visit; repeat yearly
CholesterolUp to dateLDL 128 mg/dL before atorvastatin; repeat at the three-month review
Depression screeningCompleted todayPHQ-2 score 0
Alcohol misuse screeningCompleted todayAUDIT-C score 0
Cognitive assessmentCompleted todayNormal by direct observation; Mini-Cog 5 of 5 two months ago
Falls preventionReferredPhysical therapy for gait and balance and low-vision rehabilitation for home safety
Colorectal cancer screeningOrderedNo screening result on file; stool FIT kit given, to be returned by mail
Hepatitis C screeningOrderedOne-time screening recommended for all adults through age 79; added to the three-month laboratory tests
Prostate cancer screeningNot indicatedNot recommended at 70 or older
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNo tobacco use is recorded in his social history

Guideline basis: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)

Follow-up: Physical therapy and low-vision rehabilitation referrals placed. Return the FIT kit by mail. Three-month diabetes, blood pressure, and eye pressure review in about five weeks, with HbA1c, lipids, hepatitis C screening, and the first zoster dose. Next annual wellness visit in one year. Next scheduled visit 2003-05-29: three-month diabetes, blood pressure, and eye pressure review. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He has a written health care directive and has named a health care agent; a copy is now in the chart. He described what matters most to him: keeping the sight he has left, staying at home, and continuing to write and record. The discussion covered how to make his wishes known if he could not speak for himself and how to keep the directive with his agent. He will review his wishes with his agent and revisit them at a future visit. [S]